FUNDAMENTALS · Fundamentals · SG Healthcare

Embracing Future Holdings (8YY) Fundamentals 2026 — Revenue Analysis | SniperIQ

Embracing Future Holdings (8YY) is a SG-listed Healthcare company in Medical - Diagnostics & Research with a market capitalization of S$68M, trading at S$0.04 on the SES. This SniperIQ fundamentals page covers Embracing Future Holdings's valuation, profitability (net margin -75.3%), revenue (S$5M in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.

Market CapS$68M
Net Margin-75.3%
Revenue (FY25)S$5M

Full research coverage

  • 8-Quarter Revenue & Margin Trend
  • Debt Maturity & Coverage
  • Peer Valuation Comparison
  • Free Cash Flow & Owner Earnings
  • AI Signal + Institutional Flow
  • DCF Valuation Model

Frequently Asked Questions

What is Embracing Future Holdings's market cap?

Embracing Future Holdings (8YY) has a market capitalization of approximately S$68M, trading at S$0.04 on the SES. Market cap moves with the live share price.

What is Embracing Future Holdings's P/E ratio?

Embracing Future Holdings's trailing twelve-month P/E ratio is not meaningful (negative or nil earnings), with a price-to-book (P/B) of 44.9x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.

How profitable is Embracing Future Holdings?

Embracing Future Holdings runs a net profit margin of -75.3%, a gross margin of 36.9%, and an operating margin of -60.4%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.

How much revenue does Embracing Future Holdings generate?

Embracing Future Holdings reported revenue of S$5M for fiscal year 2025, with net income of -S$4M and earnings per share (EPS) of -0.0023. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.

Does Embracing Future Holdings pay a dividend?

Embracing Future Holdings does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.

Is Embracing Future Holdings financially healthy?

Embracing Future Holdings carries a debt-to-equity ratio of 1.58x and a current ratio of 1.17x, with a market beta of 0.62. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.

Is Embracing Future Holdings a good stock to buy in 2026?

SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Embracing Future Holdings (8YY) the key facts are: market cap S$68M, revenue S$5M, 52-week range 0.021-0.092. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.

Track Embracing Future Holdings's full fundamentals live

Get Embracing Future Holdings's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.

Related: Zhengye Biotechnology Holding (ZYBT) fundamentals · DocGo (DCGO) fundamentals · MindWalk Holdings (HYFT) fundamentals · XBiotech (XBIT) fundamentals · All stock fundamentals · AI signal library
Research Hubs: Fundamentals library · Screeners · Institutional positioning · Super investors · Daily signals · Platform comparisons